RNF114 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.471000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.542400E-02
Normal-vs-Stage2
3.078600E-01
Normal-vs-Stage3
9.792300E-02
Normal-vs-Stage4
3.214800E-01
Stage1-vs-Stage2
3.247200E-01
Stage1-vs-Stage3
3.379200E-01
Stage1-vs-Stage4
3.806600E-01
Stage2-vs-Stage3
1.053610E-01
Stage2-vs-Stage4
8.680000E-01
Stage3-vs-Stage4
2.226200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.525000E-01
Normal-vs-AfricanAmerican
2.085200E-01
Normal-vs-Asian
4.485800E-01
Caucasian-vs-AfricanAmerican
9.552200E-01
Caucasian-vs-Asian
7.131000E-01
AfricanAmerican-vs-Asian
7.782200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.307400E-01
Normal-vs-Female
1.757840E-01
Male-vs-Female
2.193600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.767200E-01
Normal-vs-Age(41-60Yrs)
3.388200E-01
Normal-vs-Age(61-80Yrs)
2.454600E-01
Normal-vs-Age(81-100Yrs)
1.393790E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.487000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.011400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.424600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.620390E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.019200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.137200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.493600E-02
Normal-vs-Daily Drinker
3.814400E-01
Normal-vs-Weekly Drinker
4.649800E-01
Normal-vs-Occasional Drinker
6.158200E-01
Normal-vs-Social Drinker
6.601000E-01
Non Drinker-vs-Daily Drinker
1.929950E-01
Non Drinker-vs-Weekly Drinker
2.124200E-01
Non Drinker-vs-Occasional Drinker
1.213880E-02
Non Drinker-vs-Social Drinker
1.632790E-01
Daily Drinker-vs-Weekly Drinker
9.133800E-01
Daily Drinker-vs-Occasional Drinker
3.191000E-01
Daily Drinker-vs-Social Drinker
6.105800E-01
Weekly Drinker-vs-Occasional Drinker
4.487800E-01
Weekly Drinker-vs-Social Drinker
7.301000E-01
Occasional Drinker-vs-Social Drinker
7.873600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.940200E-01
Normal-vs-Grade 2
9.177400E-01
Normal-vs-Grade 3
8.512000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.739600E-02
Grade 1-vs-Grade 3
1.203670E-02
Grade 1-vs-Grade 4
9.940200E-01
Grade 2-vs-Grade 3
1.388400E-01
Grade 2-vs-Grade 4
9.177400E-01
Grade 3-vs-Grade 4
8.512000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.426200E-01
Normal-vs-NonDiabetic
2.358000E-01
Diabetic-vs-NonDiabetic
6.215800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.370800E-01
Normal-vs-NoPancreatitis
2.243000E-01
Pancreatitis-vs-NoPancreatitis
4.668800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.941570E-01
Normal-vs-N1
2.701600E-01
N0-vs-N1
6.901600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.218600E-01
Normal-vs-TP53-NonMutant
2.524600E-01
TP53-Mutant-vs-TP53-NonMutant
1.998280E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
